NHS
Basic information
Region (hg38): X:17375200-17735994
Links
Phenotypes
GenCC
Source:
- Nance-Horan syndrome (Definitive), mode of inheritance: XLR
- cataract 40 (Definitive), mode of inheritance: XLR
- Nance-Horan syndrome (Moderate), mode of inheritance: XL
- Nance-Horan syndrome (Supportive), mode of inheritance: XL
- early-onset nuclear cataract (Supportive), mode of inheritance: AD
- Nance-Horan syndrome (Definitive), mode of inheritance: XL
- Nance-Horan syndrome (Strong), mode of inheritance: XL
- Nance-Horan syndrome (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Nance-Horan syndrome; Cataract 40 | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 4470901; 458526; 11836358; 14564667; 15623749; 16736028; 17256798; 19414485; 20882036; 25266737 |
ClinVar
This is a list of variants' phenotypes submitted to
- Nance-Horan syndrome (29 variants)
- not provided (13 variants)
- Cataract 40 (2 variants)
- Inborn genetic diseases (2 variants)
- Nance-Horan syndrome;X-linked syndromic intellectual disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NHS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 81 | 22 | 110 | |||
missense | 169 | 48 | 32 | 250 | ||
nonsense | 15 | 17 | ||||
start loss | 0 | |||||
frameshift | 24 | 27 | ||||
inframe indel | 16 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 4 | 3 | 1 | 8 | ||
non coding | 16 | 13 | 33 | |||
Total | 43 | 6 | 190 | 151 | 68 |
Variants in NHS
This is a list of pathogenic ClinVar variants found in the NHS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-17375203-G-A | Benign (Sep 11, 2018) | |||
X-17375755-G-T | Uncertain significance (May 06, 2023) | |||
X-17375806-C-T | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
X-17375806-CGGCG-C | Nance-Horan syndrome | Pathogenic (Oct 25, 2020) | ||
X-17375820-C-A | Inborn genetic diseases | Likely benign (Dec 18, 2017) | ||
X-17375838-G-C | Nance-Horan syndrome | Likely benign (Jul 10, 2023) | ||
X-17375841-CG-C | Nance-Horan syndrome | Pathogenic (Dec 02, 2023) | ||
X-17375843-G-T | Nance-Horan syndrome | Uncertain significance (Aug 10, 2023) | ||
X-17375847-C-A | Inborn genetic diseases | Likely benign (May 31, 2017) | ||
X-17375851-G-C | Inborn genetic diseases | Uncertain significance (Jul 26, 2022) | ||
X-17375857-C-A | Inborn genetic diseases • Nance-Horan syndrome | Conflicting classifications of pathogenicity (Dec 28, 2023) | ||
X-17375863-C-T | Nance-Horan syndrome | Uncertain significance (Nov 01, 2022) | ||
X-17375864-C-G | - | no classification for the single variant (-) | ||
X-17375865-GC-G | - | no classification for the single variant (-) | ||
X-17375872-C-T | Nance-Horan syndrome | Pathogenic (Jan 01, 2005) | ||
X-17375877-G-T | Nance-Horan syndrome | Likely benign (May 20, 2022) | ||
X-17375884-C-G | NHS-related disorder | Uncertain significance (Sep 27, 2023) | ||
X-17375890-G-GA | Nance-Horan syndrome | Pathogenic (Nov 10, 2023) | ||
X-17375893-C-G | Nance-Horan syndrome | Uncertain significance (Dec 18, 2022) | ||
X-17375904-C-T | Uncertain significance (Jun 01, 2015) | |||
X-17375909-C-T | Nance-Horan syndrome;Cataract 40 • Nance-Horan syndrome • Inborn genetic diseases | Conflicting classifications of pathogenicity (Oct 13, 2023) | ||
X-17375922-G-A | Nance-Horan syndrome | Likely benign (Dec 08, 2022) | ||
X-17375933-G-A | Inborn genetic diseases | Uncertain significance (May 09, 2023) | ||
X-17375933-GC-AA | not specified • Nance-Horan syndrome;Cataract 40 • Nance-Horan syndrome | Uncertain significance (Dec 08, 2023) | ||
X-17375934-C-A | Likely benign (Sep 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NHS | protein_coding | protein_coding | ENST00000380060 | 8 | 360572 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000507 | 120940 | 1 | 1 | 120942 | 0.00000827 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.82 | 495 | 623 | 0.795 | 0.0000505 | 10612 |
Missense in Polyphen | 196 | 297.75 | 0.65828 | 4898 | ||
Synonymous | 1.30 | 221 | 247 | 0.895 | 0.0000203 | 3406 |
Loss of Function | 5.42 | 0 | 34.1 | 0.00 | 0.00000278 | 600 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000253 | 0.0000185 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function in cell morphology by maintaining the integrity of the circumferential actin ring and controlling lamellipod formation. Involved in the regulation eye, tooth, brain and craniofacial development. {ECO:0000269|PubMed:20332100}.;
- Disease
- DISEASE: Cataract 40 (CTRCT40) [MIM:302200]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT40 manifests as a congenital nuclear opacity with severe visual impairment in affected males. Heterozygous females have suture cataracts and only slight reduction in vision. In some cases, cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. {ECO:0000269|PubMed:19414485}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by copy number variations predicted to result in altered transcriptional regulation of the NHS gene: a 0.8 Mb segmental duplication-triplication encompassing the NHS, SCML1 and RAI2 genes, and an 4.8 kb intragenic deletion in NHS intron 1.;
Recessive Scores
- pRec
- 0.148
Intolerance Scores
- loftool
- rvis_EVS
- -0.73
- rvis_percentile_EVS
- 14.24
Haploinsufficiency Scores
- pHI
- 0.177
- hipred
- Y
- hipred_score
- 0.715
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0565
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nhs
- Phenotype
- vision/eye phenotype;
Gene ontology
- Biological process
- lens development in camera-type eye;cell differentiation
- Cellular component
- Golgi apparatus;bicellular tight junction;focal adhesion;apical plasma membrane;nuclear body;lamellipodium;cell junction
- Molecular function